An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Experimental Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.
Several experts said the popularity for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer regulations, risking penalties, prosecution or prison.
Platform Response and Content Removal
According to TikTok, the service has taken down problematic material and prohibited related keywords and search suggestions. The company stated it was committed to keeping the platform safe and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Research also found groups with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.
Within moments of entering one group, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, health issues or previous experience.
Product Details and Pricing
Inside these groups, messages show dark colored parcels with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give conflicting responses varying between a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for the messaging service said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.
Her staff has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly serious health risks”.
